Centre Hospitalier Universitaire de Bordeaux / CHU Bordeaux

Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program (2024) Azizi M, Sharp AS, Fisher ND, Weber MA, Lobo MD, Daemen J, Lurz P, et al. Journal article Cardiovascular and health cost impacts of cuff blood pressure underestimation and overestimation of invasive aortic systolic blood pressure (2023) Fonseca R, Palmer AJ, Picone DS, Cox IA, Schultz MG, Black JA, Bos WJ, et al. Journal article Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation (2023) Ruggeri A, De Wreede LC, Muller CR, Crivello P, Bonneville EF, Petersdorf EW, Socie G, et al. Journal article Sex Differences in Blood Pressure and Potential Implications for Cardiovascular Risk Management (2023) Picone DS, Stoneman E, Cremer A, Schultz MG, Otahal P, Hughes AD, Black JA, et al. Journal article Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study. (2023) Tan BWL, Tan BWQ, Tan ALM, Schriver ER, Gutierrez-Sacristan A, Das P, Yuan W, et al. Journal article Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial (2022) Azizi M, Mahfoud F, Weber MA, Sharp ASP, Schmieder R, Lurz P, Lobo MD, et al. Journal article Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort (2022) Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, et al. Journal article HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022) Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, et al. Conference contribution Twenty-Four Month Results in Patients With Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial (2022) Bloch M, Kirtane A, Mahfoud F, Azizi M, Basile J, Daemen J, Saxena M, et al. Conference contribution A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022) Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al. Conference contribution